Zhan M - Search Results

1

CXCL12 and IL7R as Novel Therapeutic Targets for Liver Hepatocellular Carcinoma Are Correlated With Somatic Mutations and the Tumor Immunological Microenvironment.

He K, Liu S, Xia Y, Xu J, Liu F, Xiao J, Li Y, Ding Q, Lu L, Xiang G, Zhan M. He K, et al. Among authors: zhan m. Front Oncol. 2020 Dec 4;10:574853. doi: 10.3389/fonc.2020.574853. eCollection 2020. Front Oncol. 2020. PMID: 33344233 Free PMC article.

2

[Prognostic significance of serum level of vascular endothelial growth factor receptor-2 in hepatocellular carcinoma patients after transcatheter arterial chemoembolization].

Meng QW, Li Y, Hu BS, Shao PJ, Zhan MX, Yu XY, Lu LG. Meng QW, et al. Zhonghua Yi Xue Za Zhi. 2013 Jan 29;93(5):341-4. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23660204 Chinese.

3

[Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance].

Zhan MX, Li Y, Hu BS, Shao PJ, Meng QW, He X, Huang JW, Lu LG. Zhan MX, et al. Zhonghua Yi Xue Za Zhi. 2013 Jun 18;93(23):1830-2. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24124720 Chinese.

4

[Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].

Zhao Y, Li Y, Hu B, He X, Huang J, Zhan M, Lu L. Zhao Y, et al. Among authors: zhan m. Zhonghua Yi Xue Za Zhi. 2014 Feb 11;94(5):390-2. Zhonghua Yi Xue Za Zhi. 2014. PMID: 24746091 Chinese.

5

Sorafenib continuation after first disease progression could reduce disease flares and provide survival benefits in patients with hepatocellular carcinoma: a pilot retrospective study.

Fu SR, Zhang YQ, Li Y, Hu BS, He X, Huang JW, Zhan MX, Lu LG, Li JP. Fu SR, et al. Asian Pac J Cancer Prev. 2014;15(7):3151-6. doi: 10.7314/apjcp.2014.15.7.3151. Asian Pac J Cancer Prev. 2014. PMID: 24815462 Free article.

6

Serum microRNA-210 as a predictive biomarker for treatment response and prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Zhan M, Li Y, Hu B, He X, Huang J, Zhao Y, Fu S, Lu L. Zhan M, et al. J Vasc Interv Radiol. 2014 Aug;25(8):1279-1287.e1. doi: 10.1016/j.jvir.2014.04.013. Epub 2014 Jun 13. J Vasc Interv Radiol. 2014. PMID: 24935355

7

Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.

Zheng YB, Huang JW, Zhan MX, Zhao W, Liu B, He X, Li Y, Hu BS, Lu LG. Zheng YB, et al. Tumour Biol. 2014 Nov;35(11):11473-81. doi: 10.1007/s13277-014-2478-8. Epub 2014 Aug 16. Tumour Biol. 2014. PMID: 25123269

8

The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib.

Zheng YB, Zhan MX, Zhao W, Liu B, Huang JW, He X, Fu SR, Zhao Y, Li Y, Hu BS, Lu LG. Zheng YB, et al. Med Oncol. 2014 Oct;31(10):209. doi: 10.1007/s12032-014-0209-z. Epub 2014 Sep 3. Med Oncol. 2014. PMID: 25182707

9

Usp7 promotes medulloblastoma cell survival and metastasis by activating Shh pathway.

Zhan M, Sun X, Liu J, Li Y, Li Y, He X, Zhou Z, Lu L. Zhan M, et al. Biochem Biophys Res Commun. 2017 Mar 4;484(2):429-434. doi: 10.1016/j.bbrc.2017.01.144. Epub 2017 Jan 27. Biochem Biophys Res Commun. 2017. PMID: 28137592

10

DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo.

Du H, Liu Y, Chen X, Yu X, Hou X, Li H, Zhan M, Lin S, Lu L, Yuan S, Sun L. Du H, et al. Among authors: zhan m. Eur J Pharmacol. 2018 Jan 5;818:124-131. doi: 10.1016/j.ejphar.2017.10.014. Epub 2017 Nov 5. Eur J Pharmacol. 2018. PMID: 29037767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,270 results

Search Page

Filters